1. Home
  2. CABA vs BZUN Comparison

CABA vs BZUN Comparison

Compare CABA & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CABA
  • BZUN
  • Stock Information
  • Founded
  • CABA 2017
  • BZUN 2007
  • Country
  • CABA United States
  • BZUN China
  • Employees
  • CABA N/A
  • BZUN N/A
  • Industry
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • BZUN Catalog/Specialty Distribution
  • Sector
  • CABA Health Care
  • BZUN Consumer Discretionary
  • Exchange
  • CABA Nasdaq
  • BZUN Nasdaq
  • Market Cap
  • CABA 157.4M
  • BZUN 131.7M
  • IPO Year
  • CABA 2019
  • BZUN N/A
  • Fundamental
  • Price
  • CABA $1.63
  • BZUN $2.61
  • Analyst Decision
  • CABA Strong Buy
  • BZUN Buy
  • Analyst Count
  • CABA 7
  • BZUN 2
  • Target Price
  • CABA $14.43
  • BZUN $3.20
  • AVG Volume (30 Days)
  • CABA 3.0M
  • BZUN 262.6K
  • Earning Date
  • CABA 08-07-2025
  • BZUN 08-27-2025
  • Dividend Yield
  • CABA N/A
  • BZUN N/A
  • EPS Growth
  • CABA N/A
  • BZUN N/A
  • EPS
  • CABA N/A
  • BZUN N/A
  • Revenue
  • CABA N/A
  • BZUN $1,310,110,798.00
  • Revenue This Year
  • CABA N/A
  • BZUN $5.27
  • Revenue Next Year
  • CABA N/A
  • BZUN $3.46
  • P/E Ratio
  • CABA N/A
  • BZUN N/A
  • Revenue Growth
  • CABA N/A
  • BZUN 6.77
  • 52 Week Low
  • CABA $0.99
  • BZUN $2.11
  • 52 Week High
  • CABA $8.77
  • BZUN $4.38
  • Technical
  • Relative Strength Index (RSI)
  • CABA 44.25
  • BZUN 46.57
  • Support Level
  • CABA $1.65
  • BZUN $2.48
  • Resistance Level
  • CABA $1.68
  • BZUN $2.70
  • Average True Range (ATR)
  • CABA 0.14
  • BZUN 0.15
  • MACD
  • CABA -0.05
  • BZUN 0.00
  • Stochastic Oscillator
  • CABA 23.53
  • BZUN 29.18

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

About BZUN Baozun Inc.

Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).

Share on Social Networks: